Clinical Trial

A Study of GZR4 Injection at Different Injection Sites

Recruiting Phase 1
View on ClinicalTrials.gov →
Record status
This record was last updated August 12, 2024 (before its estimated August 31, 2024 completion). Its status may not reflect the trial's current state.
Summary
This trial is conducted in China. This study is a randomized, single-center, open, three-period crossover trial in healthy subjects to compare the PK, PD, and safety of a single administration of GZR4 at different injection sites (abdomen, deltoid region of upper arm, and thigh).
Trial Details
NCT Number NCT06548906
Lead Sponsor Gan and Lee Pharmaceuticals, USA
Conditions Healthy Subjects
Enrollment 24 participants
Start Date 2024-05-08
Primary Completion 2024-08-31 (estimated)
Study Completion 2024-08-31 (estimated)
Updated on ClinicalTrials.gov 2024-08-12